165 related articles for article (PubMed ID: 22560628)
1. β-Lapachone analogs with enhanced antiproliferative activity.
Ríos-Luci C; Bonifazi EL; León LG; Montero JC; Burton G; Pandiella A; Misico RI; Padrón JM
Eur J Med Chem; 2012 Jul; 53():264-74. PubMed ID: 22560628
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
[TBL] [Abstract][Full Text] [Related]
3. Lawsone, Juglone, and β-Lapachone Derivatives with Enhanced Mitochondrial-Based Toxicity.
Anaissi-Afonso L; Oramas-Royo S; Ayra-Plasencia J; Martín-Rodríguez P; García-Luis J; Lorenzo-Castrillejo I; Fernández-Pérez L; Estévez-Braun A; Machín F
ACS Chem Biol; 2018 Aug; 13(8):1950-1957. PubMed ID: 29878754
[TBL] [Abstract][Full Text] [Related]
4. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.
Löcken H; Clamor C; Müller K
J Nat Prod; 2018 Jul; 81(7):1636-1644. PubMed ID: 30003778
[TBL] [Abstract][Full Text] [Related]
5. Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones.
Frydman B; Marton LJ; Sun JS; Neder K; Witiak DT; Liu AA; Wang HM; Mao Y; Wu HY; Sanders MM; Liu LF
Cancer Res; 1997 Feb; 57(4):620-7. PubMed ID: 9044837
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of pharmacologically important naphthoquinones and anticancer activity of 2-benzyllawsone through DNA topoisomerase-II inhibition.
Kumar BS; Ravi K; Verma AK; Fatima K; Hasanain M; Singh A; Sarkar J; Luqman S; Chanda D; Negi AS
Bioorg Med Chem; 2017 Feb; 25(4):1364-1373. PubMed ID: 28094224
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of β-lapachone-monastrol hybrids as potential anticancer agents.
Wu L; Ma X; Yang X; Zhang C
Eur J Med Chem; 2020 Oct; 203():112594. PubMed ID: 32682198
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and potent antitumor activity of new arylamino derivatives of nor-beta-lapachone and nor-alpha-lapachone.
da Silva Júnior EN; de Souza MC; Pinto AV; Pinto Mdo C; Goulart MO; Barros FW; Pessoa C; Costa-Lotufo LV; Montenegro RC; de Moraes MO; Ferreira VF
Bioorg Med Chem; 2007 Nov; 15(22):7035-41. PubMed ID: 17827021
[TBL] [Abstract][Full Text] [Related]
9. β-Lapachone and its iodine derivatives cause cell cycle arrest at G
Dias RB; de Araújo TBS; de Freitas RD; Rodrigues ACBDC; Sousa LP; Sales CBS; Valverde LF; Soares MBP; Dos Reis MG; Coletta RD; Ramos EAG; Camara CA; Silva TMS; Filho JMB; Bezerra DP; Rocha CAG
Free Radic Biol Med; 2018 Oct; 126():87-100. PubMed ID: 30071298
[TBL] [Abstract][Full Text] [Related]
10. PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage.
Su X; Wang J; Jiang L; Chen Y; Lu T; Mendonca MS; Huang X
Cancer Lett; 2021 Oct; 519():304-314. PubMed ID: 34329742
[TBL] [Abstract][Full Text] [Related]
11. Yeast cytotoxic sensitivity to the antitumour agent β-lapachone depends mainly on oxidative stress and is largely independent of microtubule- or topoisomerase-mediated DNA damage.
Ramos-Pérez C; Lorenzo-Castrillejo I; Quevedo O; García-Luis J; Matos-Perdomo E; Medina-Coello C; Estévez-Braun A; Machín F
Biochem Pharmacol; 2014 Nov; 92(2):206-19. PubMed ID: 25241291
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
Jeon KH; Yu HB; Kwak SY; Kwon Y; Na Y
Bioorg Med Chem; 2016 Nov; 24(22):5921-5928. PubMed ID: 27707625
[TBL] [Abstract][Full Text] [Related]
13. Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation.
Petronzi C; Festa M; Peduto A; Castellano M; Marinello J; Massa A; Capasso A; Capranico G; La Gatta A; De Rosa M; Caraglia M; Filosa R
J Exp Clin Cancer Res; 2013 Apr; 32(1):24. PubMed ID: 23631805
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
[TBL] [Abstract][Full Text] [Related]
15. Iridium(iii) complexes as mitochondrial topoisomerase inhibitors against cisplatin-resistant cancer cells.
He L; Xiong K; Wang L; Guan R; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2021 Aug; 57(67):8308-8311. PubMed ID: 34319315
[TBL] [Abstract][Full Text] [Related]
16. Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma.
Lim SM; Jeong Y; Lee S; Im H; Tae HS; Kim BG; Park HD; Park J; Hong S
J Med Chem; 2015 Nov; 58(21):8491-502. PubMed ID: 26496175
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of lapachol, β-lapachone and related synthetic 1,4-naphthoquinones against oesophageal cancer cells.
Sunassee SN; Veale CG; Shunmoogam-Gounden N; Osoniyi O; Hendricks DT; Caira MR; de la Mare JA; Edkins AL; Pinto AV; da Silva Júnior EN; Davies-Coleman MT
Eur J Med Chem; 2013 Apr; 62():98-110. PubMed ID: 23353747
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs.
Park HJ; Lee HJ; Lee EJ; Hwang HJ; Shin SH; Suh ME; Kim C; Kim HJ; Seo EK; Lee SK
Biosci Biotechnol Biochem; 2003 Sep; 67(9):1944-9. PubMed ID: 14519980
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction.
Han Y; Shi D; Li J
Med Sci Monit; 2019 Nov; 25():8995-9002. PubMed ID: 31770363
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I.
Boothman DA; Trask DK; Pardee AB
Cancer Res; 1989 Feb; 49(3):605-12. PubMed ID: 2535961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
